AGHAZADEH BEHZAD purchased 342.8% of their position (2.39M shares) of SCRIBE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $36.26M — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/29/2026ACC: 0000902664-26-003270
DirectorOther
Since Jul 2026
+2.39M
Net shares
Net buyer
$36.26M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
2.39M acquired
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Indirect
Shares
+2.33M
Price / share
$15.00
Trade value
$35M
% of position
334.5%
7/24/2026
697.65K→3.03M
Common Stock, par value $0.0001 per share
Indirect
Shares
+50K
Price / share
$22.31
Trade value
$1.12M
% of position
1.6%
7/24/2026
3.03M→3.08M
Common Stock, par value $0.0001 per share
Indirect
Shares
+7.91K
Price / share
$18.25
Trade value
$144.27K
% of position
0.3%
7/28/2026
3.08M→3.09M
Total
Net shares
+2.39M
Net value
$36.26M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 7/24/2026 | P · Purchase | +2.33M | $15.00 | $35M | 334.5% | 697.65K | 3.03M |
| Common Stock, par value $0.0001 per share Indirect | 7/24/2026 | P · Purchase | +50K | $22.31 | $1.12M | 1.6% | 3.03M | 3.08M |
| Common Stock, par value $0.0001 per share Indirect | 7/28/2026 | P · Purchase | +7.91K | $18.25 | $144.27K | 0.3% | 3.08M | 3.09M |
| Total | +2.39M | $36.26M | ||||||
Derivative Transactions0
No derivative transactions reported